Mt. San Rafael Hospital Selects Oracle Health To Optimize Financial Performance, Enhance Patient Care
Will use Oracle Health Clinical AI Agent to reduce administrative burden, enable doctors to spend more time with patientsAUSTIN, Texas,...
EHR
Mt. San Rafael Hospital Selects Oracle Health To Optimize Financial Performance, Enhance Patient Care
Will use Oracle Health Clinical AI Agent to reduce administrative burden, enable doctors to spend more time with patientsAUSTIN, Texas,...
Annovis to Host Corporate Update Webinar on January 28, 2026
MALVERN, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical...
Annovis to Host Corporate Update Webinar on January 28, 2026
MALVERN, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical...
Annovis to Host Corporate Update Webinar on January 28, 2026
MALVERN, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical...
Atomathic Launches AISIR For Radar — Physical AI Reasoning Technology for Safety-Critical Perception
New White Paper Details the Dual-System Architecture Behind AISIR for Radar™ and How Atomathic Closes the Industry's Reliability GapPLEASANTON, Calif.,...
Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease
New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health...
Healthcare IT Market Set to More Than Double by 2030 Growing at 15.24% CAGR, Reports Mordor Intelligence
HYDERABAD, India, December 15, 2025 /PRNewswire/ -- According to Mordor Intelligence, the healthcare IT market is valued at USD 413.14...
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly...
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025
SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (NASDAQ:VSEE) a leader in innovative telemedicine...
Smart Meter and eClinicalWorks More Than Double RPM Adoption in 2025, Powering a New Era of Connected Care for Patients
TAMPA, Fla.--(BUSINESS WIRE)--Smart Meter, the leader in Cellular RPM™ and the nation’s most trusted source of patient-generated vital health data,...
BrainCheck Awarded $500K NIH SBIR Phase I Grant to Advance eConsult Platform for Cognitive Care
AUSTIN, Texas--(BUSINESS WIRE)--#CognitiveHealth--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR...
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE, VSEEW), a leading provider of...
Cadwell and Medical Informatics Corp. Announce Partnership to Bring Neurodiagnostic Data into Clinical Intelligence Ecosystem
KENNEWICK, Wash. and HOUSTON, Dec. 11, 2025 /PRNewswire/ -- Cadwell, a global leader in neurodiagnostic and monitoring solutions, and Medical...
Geneva PE Announces Funding and Launch of NXXIM (Nexus Enterprise Imaging LLC), an AI-Powered Medical Imaging Platform
Geneva PE's funding of NXXIM will create a cutting-edge AI platform that unifies patient data and empowers clinicians to make...
KNOBLOCH Information Group, BEN, and Skye Inteligencia LATAM Form Skye Salud to Modernize Healthcare in Mexico with Sovereign AI
WILMINGTON, Del. and MEXICO CITY, Dec. 11, 2025 /PRNewswire/ -- Brand Engagement Network, Inc. (Nasdaq: BNAI) ("BEN"), a developer of...
Ritten Announces $35M Series B Investment Led by Five Elms Capital
PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35...
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease Results show, for...
SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions
GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ -- ModuleMD, ranked as one of America's fastest-growing companies on the Inc. 5000...
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”)...